| pubmed-article:2496636 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2496636 | lifeskim:mentions | umls-concept:C0021079 | lld:lifeskim |
| pubmed-article:2496636 | lifeskim:mentions | umls-concept:C0015506 | lld:lifeskim |
| pubmed-article:2496636 | lifeskim:mentions | umls-concept:C0574032 | lld:lifeskim |
| pubmed-article:2496636 | lifeskim:mentions | umls-concept:C0368953 | lld:lifeskim |
| pubmed-article:2496636 | lifeskim:mentions | umls-concept:C0439661 | lld:lifeskim |
| pubmed-article:2496636 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
| pubmed-article:2496636 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:2496636 | pubmed:dateCreated | 1989-5-26 | lld:pubmed |
| pubmed-article:2496636 | pubmed:abstractText | To evaluate the effectiveness of combined cyclophosphamide, vincristine, and prednisone (CVP) therapy after antigenic stimulation with factor VIII in the eradication of factor VIII inhibitor. | lld:pubmed |
| pubmed-article:2496636 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2496636 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2496636 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2496636 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2496636 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2496636 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2496636 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:2496636 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2496636 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2496636 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2496636 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2496636 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2496636 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2496636 | pubmed:month | May | lld:pubmed |
| pubmed-article:2496636 | pubmed:issn | 0003-4819 | lld:pubmed |
| pubmed-article:2496636 | pubmed:author | pubmed-author:ChiuA YAY | lld:pubmed |
| pubmed-article:2496636 | pubmed:author | pubmed-author:LianE CEC | lld:pubmed |
| pubmed-article:2496636 | pubmed:author | pubmed-author:LarcadaA FAF | lld:pubmed |
| pubmed-article:2496636 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2496636 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:2496636 | pubmed:volume | 110 | lld:pubmed |
| pubmed-article:2496636 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2496636 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2496636 | pubmed:pagination | 774-8 | lld:pubmed |
| pubmed-article:2496636 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:2496636 | pubmed:meshHeading | pubmed-meshheading:2496636-... | lld:pubmed |
| pubmed-article:2496636 | pubmed:meshHeading | pubmed-meshheading:2496636-... | lld:pubmed |
| pubmed-article:2496636 | pubmed:meshHeading | pubmed-meshheading:2496636-... | lld:pubmed |
| pubmed-article:2496636 | pubmed:meshHeading | pubmed-meshheading:2496636-... | lld:pubmed |
| pubmed-article:2496636 | pubmed:meshHeading | pubmed-meshheading:2496636-... | lld:pubmed |
| pubmed-article:2496636 | pubmed:meshHeading | pubmed-meshheading:2496636-... | lld:pubmed |
| pubmed-article:2496636 | pubmed:meshHeading | pubmed-meshheading:2496636-... | lld:pubmed |
| pubmed-article:2496636 | pubmed:meshHeading | pubmed-meshheading:2496636-... | lld:pubmed |
| pubmed-article:2496636 | pubmed:meshHeading | pubmed-meshheading:2496636-... | lld:pubmed |
| pubmed-article:2496636 | pubmed:meshHeading | pubmed-meshheading:2496636-... | lld:pubmed |
| pubmed-article:2496636 | pubmed:meshHeading | pubmed-meshheading:2496636-... | lld:pubmed |
| pubmed-article:2496636 | pubmed:meshHeading | pubmed-meshheading:2496636-... | lld:pubmed |
| pubmed-article:2496636 | pubmed:meshHeading | pubmed-meshheading:2496636-... | lld:pubmed |
| pubmed-article:2496636 | pubmed:meshHeading | pubmed-meshheading:2496636-... | lld:pubmed |
| pubmed-article:2496636 | pubmed:meshHeading | pubmed-meshheading:2496636-... | lld:pubmed |
| pubmed-article:2496636 | pubmed:meshHeading | pubmed-meshheading:2496636-... | lld:pubmed |
| pubmed-article:2496636 | pubmed:year | 1989 | lld:pubmed |
| pubmed-article:2496636 | pubmed:articleTitle | Combination immunosuppressive therapy after factor VIII infusion for acquired factor VIII inhibitor. | lld:pubmed |
| pubmed-article:2496636 | pubmed:affiliation | University of Miami School of Medicine, Florida. | lld:pubmed |
| pubmed-article:2496636 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2496636 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:2496636 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
| pubmed-article:2496636 | pubmed:publicationType | Case Reports | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2496636 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2496636 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2496636 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2496636 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2496636 | lld:pubmed |
